Drug helps women retain fertility after chemo

A short course of goserelin  in conjunction with chemotherapy reduces the risk of ovarian failure in premenopausal women with hormone-receptor-negative breast cancer, a landmark international study has found.

The researchers say these findings have important clinical implications.

The study of more than 250 patients -  randomised to either standard chemotherapy plus concurrent treatment with the gonadotropin-releasing hormone agonist goserelin, or to chemotherapy - shows those who received